Mehmet Kocak to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Mehmet Kocak has written about Carcinoma, Hepatocellular.
Connection Strength
0.150
-
No apparent benefit of preemptive sorafenib therapy in liver transplant recipients with advanced hepatocellular carcinoma on explant. Clin Transplant. 2018 05; 32(5):e13246.
Score: 0.150